Clinical Trial Update: Identification of Underlying Conditions in Men Prescribed a PDE5 Inhibitor

View source ↗

Summary

A completed clinical trial identified underlying conditions in men prescribed a PDE5 inhibitor, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Erectile Dysfunction
• Male Urogenital Diseases

Drugs mentioned

• PDE5 inhibitor (unspecified)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Erectile Dysfunction, Cardiovascular Diseases | Status: COMPLETED | Results posted: 2012-05-11